Accumulating evidence demonstrates that the oral pathobiont Fusobacterium nucleatum is
involved in the progression of an increasing number of tumors types. Thus far, the …

Genetic alterations drive tumor onset and progression. However, the cross-talk between
tumor cells and the benign components of the surrounding stroma can also promote the …

Accumulating recent evidence indicates that the human microbiome plays essential roles in
pathophysiological states, including cancer. The tumor microbiome, an emerging concept …

Primary liver tumors (PLCs) and liver metastasis currently represent the leading cause of
cancer‐related deaths worldwide due to poor outcomes, high incidence, and postsurgical …

In cancer patients, the clinical response to checkpoint-based immunotherapy is associated
with the composition and functional quality of the host microbiome. While the relevance of …

Gut microbiota influence anti-tumor immunity, often by producing immune-modulating
metabolites. However, microbes consume a variety of metabolites that may also impact host …

Microbiota colonize exposed body tissues (eg, gastrointestinal tract, skin, lungs, female
genital tract, and urogenital tracts) and unexposed sites (eg, breast). Persistent bacterial …

Vγ9Vδ2+ T cells form part of the innate immune repertoire and are activated by
phosphorylated antigens produced by many bacteria and tumors. They have long been …

Simple Summary Neuroblastoma is a highly heterogeneous malignancy with a wide range
of outcomes from spontaneous regression to fatal chemoresistant disease, as currently …

Bacteria are the constant companions of the human body throughout its life and even after
its death. The history of a human disease such as cancer and the history of microorganisms …